✦ LIBER ✦

Use of topical immunomodulators in organ transplant recipients

✍ Scribed by Bradley T. Kovach; Thomas Stasko

Book ID: 109115785
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 195 KB
Volume: 18
Category: Article
ISSN: 1396-0296
DOI: 10.1111/j.1529-8019.2005.05008.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignancies in organ transplant recipie

Malignancies in organ transplant recipients

✍ H. Myron Kauffman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Systemic and Topical Retinoids in the Ma

Systemic and Topical Retinoids in the Management of Skin Cancer in Organ Transplant Recipients

✍ Y. G. L. De Graaf; S. Euvrard; J. N. Bouwes Bavinck 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Bronchogenic carcinoma in solid organ tr

Bronchogenic carcinoma in solid organ transplant recipients

✍ Yanis Bellil; Martin J. Edelman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 271 KB

Dermatology issues in solid organ transp

Dermatology issues in solid organ transplant recipients

✍ Dr DJ Eedy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Granulocyte transfusion therapy in abdom

Granulocyte transfusion therapy in abdominal organ transplant recipients

✍ Nikhil R. Oak; Darrell J. Triulzi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract **Background:** Patients with neutropenia are at increased risk for infections. Granulocyte transfusions (GT) have had mixed success in treatment of neutropenic infections in adult patients with hematologic malignancy. This study examined the outcomes of GT therapy in neutropenic solid

Hemolytic uremic syndrome in solid-organ

Hemolytic uremic syndrome in solid-organ transplant recipients

✍ Nina Singh; Timothy Gayowski; Ignazio R. Marino 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 785 KB

Post-transplant hemolytic uremic syndrome characterized by microangiopathic hemolysis, thrombocytopenia, and renal failure is an infrequent but potentially serious complication in organ transplant recipients. Hemolytic uremic syndrome developed in 2% (2/100) of our consecutive liver transplants. We